Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Ophthalmology
GCA
Questions discussed in this category
How would you approach management of nodular scleritis in the setting of suspected GCA?
Can nodular scleritis be a presenting manifestation of GCA?
1 Answer available
Do you routinely obtain baseline vascular imaging (CTA, MRA, PET) in patients with suspected GCA, but negative temporal artery biopsy?
Per 2021 GCA Vasculitis Guidelines: low evidence, but conditional recommendation for CTA neck, chest, abd/pelvis. Is anybody following this or do you ...
2 Answers available
How long do you continue steroid-sparing agents such as tocilizumab for GCA once the disease is in remission off steroids?
1 Answer available
At what point in GCA management do you typically introduce tocilizumab?
2 Answers available
21397
17717
8388
8479
Papers discussed in this category
Ann Intern Med, 2020 Sep 22
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.
N Engl J Med,
Trial of Tocilizumab in Giant-Cell Arteritis.
Lancet, 2016 Mar 04
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Rheumatology (Oxford, England), 2015-03
Large-vessel giant cell arteritis: a cohort study.
Related Topics in Ophthalmology
Rheumatology
Uveitis and Ocular Immunology
General Internal Medicine
Neuro-Ophthalmology
Neurology
Inflammatory eye disorders
Vitreoretinal Diseases and Surgery
Cornea and External Disease
General Rheumatology
Radiation Oncology